Integrative neuroscience approach to predict ADHD stimulant response (Q34531941)

2 August 2017

1 reference

title

Integrative neuroscience approach to predict ADHD stimulant response (English)

1 reference

2 August 2017

1 reference

Daniel F Hermens

1

1 reference

2 August 2017

Donald L Rowe

series ordinal

2

1 reference

2 August 2017

Evian Gordon

series ordinal

3

1 reference

2 August 2017

Leanne M Williams

series ordinal

4

1 reference

2 August 2017

publication date

1 May 2006

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

2 August 2017

published in

1 reference

2 August 2017

volume

6

1 reference

2 August 2017

issue

5

1 reference

2 August 2017

page(s)

753-763

1 reference

Attention-deficit/hyperactivity disorder in adults: an overview

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Knowledge and information about ADHD: evidence of cultural differences among African-American and white parents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Biological contributions to the presentation and understanding of attention-deficit/hyperactivity disorder: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Neurobiology of attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Comorbidity in ADHD: implications for research, practice, and DSM-V.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Simultaneous EEG and EDA measures in adolescent attention deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Attention deficit/hyperactivity disorder--from brain dysfunctions to behaviour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Catecholamines in attention-deficit hyperactivity disorder: current perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

The mental health of young people in Australia: key findings from the child and adolescent component of the national survey of mental health and well-being

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Symptoms of attention-deficit hyperactivity disorder in an Italian school sample: findings of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

The diagnosis and prevalence of hyperactivity in Chinese schoolboys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Prevalence estimations of attention-deficit/hyperactivity disorder: differential diagnoses and comorbidities in a Colombian sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Mental health and social adjustment in young refugee children 3 1/2 years after their arrival in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Factorial validity, reliability of assessments and prevalence of ADHD behavioural symptoms in day and residential treatment centres for children with behavioural problems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Children and adolescents with attention deficit-hyperactivity disorder: 1. Prevalence and cost of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

The British Child and Adolescent Mental Health Survey 1999: the prevalence of DSM-IV disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Current practice in the management of Attention Deficit Disorder with Hyperactivity (ADHD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Clinical Correlates of ADHD in Females: Findings From a Large Group of Girls Ascertained From Pediatric and Psychiatric Referral Sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Attention deficit/hyperactivity disorder: characteristics, interventions and models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

The epidemiology of attention-deficit/hyperactivity disorder (ADHD): a public health view

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Neuropsychological function in adults with attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Sex differences in ADHD: conference summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Gender differences in ADHD: a meta-analysis and critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Gender differences in ADHD?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Pathophysiology of the hyperactive child syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Hyperactive children's event-related potentials fail to support underarousal and maturational-lag theories.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Are stimulants overprescribed? Treatment of ADHD in four U.S. communities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Stimulant treatment for children: a community perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

National trends in the prevalence of attention-deficit/hyperactivity disorder and the prescribing of methylphenidate among school-age children: 1990-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Medication development and testing in children and adolescents. Current problems, future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Immediate effects of methylphenidate on cognitive attention skills of children with attention-deficit-hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Methylphenidate improves working memory and set-shifting in AD/HD: relationships to baseline memory capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Predicting the response of hyperkinetic children to stimulant drugs: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Methyiphenidate vs. amphetamine: Comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Effects of stimulants on the continuous performance test (CPT): implications for CPT use and interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Neurobiology of attention deficit disorder with hyperactivity: where have we come in 50 years?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Prediction of stimulant response in children with attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Stimulant effects in attention deficit hyperactivity disorder: theoretical and empirical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Behavioral and electrophysiologic predictors of treatment response to stimulants in children with attention disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Attention-deficit/hyperactivity disorder: cognitive evoked potential (P300) topography predicts treatment response to methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Attention-deficit/hyperactivity disorder: cognitive evoked potential (P300) amplitude predicts treatment response to atomoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Predicting stimulant medication response in ADHD: evidence from an integrated profile of neuropsychological, psychophysiological and clinical factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Preliminary validity of "integneuro": a new computerized battery of neurocognitive tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

The test-retest reliability of a standardized neurocognitive and neurophysiological test battery: "neuromarker".

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

Clinical database development: characterization of EEG phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.753

21 January 2018

Identifiers

DOI

10.1586/14737175.6.5.753

1 reference

2 August 2017

1 reference